Biofrontera Inc. — Form 8-K
Filed November 20, 2026 · analyzed by the 8-K Agent
8-K
▼ Likely negative
significance 95/100
What the filing says
Biofrontera Inc. filed an 8-K on November 20, 2026 (reporting period November 16, 2026) disclosing Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. The filing provides no specific details regarding which exchange, which listing standards were violated, remediation plans, or timeline for delisting. No dollar amounts, counterparties, or quantitative metrics are disclosed in this extract.
Why this rating
Delisting is existential threat to $6.9M company—eliminates public trading, liquidity, capital access. Survival-level event.
Extracted items
Price action (we called it negative)
before filing · preread $0.53 | at our read pending | +10 min pending | +30 min pending | +1 hr pending | +4 hrs pending |
Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →
See more from November 20, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.